Complementary recognition of alternative pathway activators by decay-accelerating factor and factor H

被引:16
作者
Kraus, D
Medof, ME
Mold, C [1 ]
机构
[1] Univ New Mexico, Sch Med, Dept Mol Genet & Microbiol, Albuquerque, NM 87131 USA
[2] Case Western Reserve Univ, Inst Pathol, Cleveland, OH 44106 USA
关键词
D O I
10.1128/IAI.66.2.399-405.1998
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The alternative complement pathway (ACP) functions as a surveillance mechanism by which microorganisms are opsonized with C3b in the absence of specific antibodies, The effectiveness of the ACP relies on its ability to distinguish self from non-self. This recognition function is mediated by C3 regulatory proteins including serum factor H, membrane cofactor protein (MCP), and membrane decay-accelerating factor (DAF), ii activity against bound C3b can be increased by host components such as sialic acid and decreased by microbial polysaccharides. DAF and MCP may also recognize cell surface changes such as the presence of viral glycoproteins, since some virus-infected and tumor cells activate the ACP. In the present study, liposomes containing wild-type and mutant Salmonella minnesota lipopolysaccharide (LPS) were tested for ACP activation in serum. LPS-containing liposomes with bound C3b were then tested for their susceptibility to C3 convertase regulation by H and membrane DAF and for the sensitivity of their bound C3b to the cofactor activity of H, The results indicate that while the shortest mutant, Re595 LPS, did not induce ACP activation, R7 LPS containing an additional disaccharide did, This activation was poorly regulated by DAF but was inhibited by H. The regulatory activity of H for liposome-bound C3b, however, decreased when LPS of greater polysaccharide size was present in the membrane, In contrast the ACP activation induced by the phospholipid phosphatidylethanolamine was effectively inhibited by DAF but only poorly inhibited by H.
引用
收藏
页码:399 / 405
页数:7
相关论文
共 42 条
[1]   STRUCTURE AND FUNCTION OF THE COMPLEMENT RECEPTORS, CR-1 (CD35) AND CR-2 (CD21) [J].
AHEARN, JM ;
FEARON, DT .
ADVANCES IN IMMUNOLOGY, 1989, 46 :183-219
[2]   SEPARATION OF SELF FROM NON-SELF IN THE COMPLEMENT-SYSTEM [J].
ATKINSON, JP ;
FARRIES, T .
IMMUNOLOGY TODAY, 1987, 8 (7-8) :212-215
[3]  
Blackmore TK, 1996, J IMMUNOL, V157, P5422
[4]   PURIFICATION OF HUMAN-COMPLEMENT FACTOR-D FROM THE PERITONEAL-FLUID OF PATIENTS ON CHRONIC AMBULATORY PERITONEAL-DIALYSIS [J].
CATANA, E ;
SCHIFFERLI, JA .
JOURNAL OF IMMUNOLOGICAL METHODS, 1991, 138 (02) :265-271
[5]   COMPLEMENT ALTERNATIVE PATHWAY ACTIVATION AND CONTROL ON MEMBRANES OF HUMAN LYMPHOID B-CELL LINES [J].
CAUDWELL, V ;
PORTEU, F ;
CALENDER, A ;
PANGBURN, MK ;
HALBWACHSMECARELLI, L .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1990, 20 (12) :2643-2650
[6]   ACTIVATION OF ALTERNATIVE COMPLEMENT PATHWAY DUE TO RESISTANCE OF ZYMOSAN-BOUND AMPLIFICATION CONVERTASE TO ENDOGENOUS REGULATORY MECHANISMS [J].
FEARON, DT ;
AUSTEN, KF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1977, 74 (04) :1683-1687
[7]   REGULATION BY MEMBRANE SIALIC-ACID OF BETA-1H-DEPENDENT DECAY-DISSOCIATION OF AMPLIFICATION C3 CONVERTASE OF ALTERNATIVE COMPLEMENT PATHWAY [J].
FEARON, DT .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1978, 75 (04) :1971-1975
[8]  
FISHELSON Z, 1983, J BIOL CHEM, V258, P7411
[9]   THE MECHANISM OF ACTION OF DECAY-ACCELERATING FACTOR (DAF) DAF INHIBITS THE ASSEMBLY OF C-3 CONVERTASES BY DISSOCIATING C2A AND BB [J].
FUJITA, T ;
INOUE, T ;
OGAWA, K ;
IIDA, K ;
TAMURA, N .
JOURNAL OF EXPERIMENTAL MEDICINE, 1987, 166 (05) :1221-1228
[10]  
GROSSMAN N, 1984, J IMMUNOL, V132, P376